MedTrace Logo

Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives

NCT07071389 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-07-17

No results posted yet for this study

Summary

Prospective, controlled study. Administration of a specifically formulated supplement to women prescribed oral contraceptives. Evaluation of: a) reduction of adverse effects of the treatment; b) improvement of patients' quality of life.

Conditions

  • Contraception

Interventions

DIETARY_SUPPLEMENT

Zyxelle

Patients in the study group receive Zyxelle dietary supplement along with the oral contraceptive

DRUG

Oral contraceptive

Patients in the study group receive daily dose of estroprogestinic oral contraceptive

Sponsors & Collaborators

  • Lo.Li.Pharma s.r.l

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-08
Primary Completion
2018-12-21
Completion
2018-12-21

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07071389 on ClinicalTrials.gov